Article Details
Retrieved on: 2021-11-15 16:54:58
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The chance is cut by 89% for adults at risk of severe disease in the case of Pfizer's drug, Paxlovid. Other licensed Indian molnupiravir producers ...
Article found on: www.businesstoday.in
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here